Covid-19 has impacted the supply and demand status for many industries along the supply chain. In this report a comprehensive analysis of current global Narcotic (Opioid) Drugs market in terms of demand and supply environment is provided, as well as price trend currently and in the next few years. Global leading players are profiled with their revenue, market share, profit margin, major product portfolio and SWOT analysis. From industry perspective this report analyses supply chain, including process chart introduction, upstream key raw material and cost analysis, distributor and downstream buyer analysis. This report also includes global and regional market size and forecast, major product development trend and typical downstream segment scenario, under the context of market drivers and inhibitors analysis. According to this survey, the global Narcotic (Opioid) Drugs market is estimated to have reached Segmented by Category
Codeine
Fentanyl
Hydrocodone
Hydromorphone
Meperidine
Methadone
Others
Also Read: http://www.marketwatch.com/story/dynamics-in-post-pandemic-global-n...
Segmented by End User/Segment
Pain Relief Application
Anesthesia Application
Segmented by Country
North America
United States
Canada
Mexico
Europe
Germany
France
UK
Italy
Russia
Spain
Asia Pacific
China
Japan
Korea
Southeast Asia
India
Australasia
Central & South America
Also Read: http://www.marketwatch.com/story/june-2021-report-on-global-zinc-me...
Brazil
Argentina
Colombia
Middle East & Africa
Iran
Israel
Turkey
South Africa
Saudi Arabia
Also Read: http://www.marketwatch.com/story/june-2021-report-on-global-offshor...
Key manufacturers included in this survey
Teva
Sun Pharma
Purdue Pharma
Pfizer
Mylan
Merck
Mallinckrodt
Johnson & Johnson
Hikma Pharmaceuticals
Endo Pharmaceuticals
Collegium
Amneal Pharma
Allergan
Also Read: http://www.marketwatch.com/story/june-2021-report-on-global-electri...
TABLE OF CONTENT :
Table of Contents
1 Product Introduction and Overview
1.1 Product Definition
1.2 Product Specification
1.3 Global Market Overview
1.3.1 Global Narcotic (Opioid) Drugs Market Status and Forecast (2016-2027)
1.3.2 Global Narcotic (Opioid) Drugs Sales Value CAGR by Region
1.4 Market Drivers, Inhibitors
1.4.1 Market Drivers
1.4.2 Market Inhibitors
1.4.3 COVID-19 Impact Analysis
2 Global Narcotic (Opioid) Drugs Supply by Company
2.1 Global Narcotic (Opioid) Drugs Sales Volume by Company
2.2 Global Narcotic (Opioid) Drugs Sales Value by Company
2.3 Global Narcotic (Opioid) Drugs Price by Company
2.4 Narcotic (Opioid) Drugs Production Location and Sales Area of Main Manufacturers
2.5 Trend of Concentration Rate
3 Global and Regional Narcotic (Opioid) Drugs Market Status by Category
3.1 Narcotic (Opioid) Drugs Category Introduction
3.1.1 Codeine
3.1.2 Fentanyl
3.1.3 Hydrocodone
3.1.4 Hydromorphone
3.1.5 Meperidine
3.1.6 Methadone
3.1.7 Others
3.2 Global Narcotic (Opioid) Drugs Market by Category
3.2.1 Global Narcotic (Opioid) Drugs Sales Volume by Category (2016-2021)
3.2.2 Global Narcotic (Opioid) Drugs Sales Value by Category (2016-2021)
3.2.3 Global Narcotic (Opioid) Drugs Price by Category (2016-2021)
3.3 North America: by Category
3.4 Europe: by Category
3.5 Asia Pacific: by Category
3.6 Central & South America: by Category
3.7 Middle East & Africa: by Category
4 Global and Regional Narcotic (Opioid) Drugs Market Status by End User/Segment
4.1 Narcotic (Opioid) Drugs Segment by End User/Segment
4.1.1 Pain Relief Application
4.1.2 Anesthesia Application
4.2 Global Narcotic (Opioid) Drugs Market by End User/Segment
4.2.1 Global Narcotic (Opioid) Drugs Sales Volume by End User/Segment (2016-2021)
4.2.2 Global Narcotic (Opioid) Drugs Sales Value by End User/Segment (2016-2021)
4.2.3 Global Narcotic (Opioid) Drugs Price by End User/Segment (2016-2021)
4.3 North America: by End User/Segment
4.4 Europe: by End User/Segment
4.5 Asia Pacific: by End User/Segment
4.6 Central & South America: by End User/Segment
4.7 Middle East & Africa: by End User/Segment
5 Global Narcotic (Opioid) Drugs Market Status by Region
5.1 Global Narcotic (Opioid) Drugs Market by Region
5.1.1 Global Narcotic (Opioid) Drugs Sales Volume by Region
5.1.2 Global Narcotic (Opioid) Drugs Sales Value by Region
5.2 North America Narcotic (Opioid) Drugs Market Status
5.3 Europe Narcotic (Opioid) Drugs Market Status
5.4 Asia Pacific Narcotic (Opioid) Drugs Market Status
5.5 Central & South America Narcotic (Opioid) Drugs Market Status
5.6 Middle East & Africa Narcotic (Opioid) Drugs Market Status
6 North America Narcotic (Opioid) Drugs Market Status
6.1 North America Narcotic (Opioid) Drugs Market by Country
6.1.1 North America Narcotic (Opioid) Drugs Sales Volume by Country (2016-2021)
6.1.2 North America Narcotic (Opioid) Drugs Sales Value by Country (2016-2021)
6.2 United States
6.3 Canada
6.4 Mexico
7 Europe Narcotic (Opioid) Drugs Market Status
7.1 Europe Narcotic (Opioid) Drugs Market by Country
7.1.1 Europe Narcotic (Opioid) Drugs Sales Volume by Country (2016-2021)
7.1.2 Europe Narcotic (Opioid) Drugs Sales Value by Country (2016-2021)
ALSO READ: http://www.marketwatch.com/story/june-2021-report-on-global-lte-a-i...
7.2 Germany
7.3 France
7.4 UK
7.5 Italy
7.6 Russia
7.7 Spain
8 Asia Pacific Narcotic (Opioid) Drugs Market Status
8.1 Asia Pacific Narcotic (Opioid) Drugs Market by Country
8.1.1 Asia Pacific Narcotic (Opioid) Drugs Sales Volume by Country (2016-2021)
8.1.2 Asia Pacific Narcotic (Opioid) Drugs Sales Value by Country (2016-2021)
8.2 China
8.3 Japan
8.4 Korea
8.5 Southeast Asia
8.6 India
8.7 Australasia
9 Central & South America Narcotic (Opioid) Drugs Market Status
9.1 Central & South America Narcotic (Opioid) Drugs Market by Country
9.1.1 Central & South America Narcotic (Opioid) Drugs Sales Volume by Country (2016-2021)
9.1.2 Central & South America Narcotic (Opioid) Drugs Sales Value by Country (2016-2021)
9.2 Brazil
9.3 Argentina
9.4 Colombia
10 Middle East & Africa Narcotic (Opioid) Drugs Market Status
10.1 Middle East & Africa Narcotic (Opioid) Drugs Market by Country
10.1.1 Middle East & Africa Narcotic (Opioid) Drugs Sales Volume by Country (2016-2021)
10.1.2 Middle East & Africa Narcotic (Opioid) Drugs Sales Value by Country (2016-2021)
10.2 Iran
10.3 Israel
10.4 Turkey
10.5 South Africa
10.8 Saudi Arabia
11 Supply Chain and Manufacturing Cost Analysis
11.1 Supply Chain Analysis
11.2 Production Process Chart Analysis
11.3 Raw Materials and Key Suppliers Analysis
11.3.1 Raw Materials Introduction
11.3.2 Raw Materials Key Suppliers List
11.4 Narcotic (Opioid) Drugs Manufacturing Cost Analysis
11.5 Narcotic (Opioid) Drugs Sales Channel and Distributors Analysis
11.5.1 Narcotic (Opioid) Drugs Sales Channel
11.5.2 Narcotic (Opioid) Drugs Distributors
11.6 Narcotic (Opioid) Drugs Downstream Major Buyers
12 Global Narcotic (Opioid) Drugs Market Forecast by Category and by End User/Segment
12.1 Global Narcotic (Opioid) Drugs Sales Volume and Sales Value Forecast (2022-2027)
12.2 Global Narcotic (Opioid) Drugs Forecast by Category
12.2.1 Global Narcotic (Opioid) Drugs Sales Volume Forecast by Category
12.2.2 Global Narcotic (Opioid) Drugs Sales Value Forecast by Category
12.2.3 Global Narcotic (Opioid) Drugs Price Forecast by Category
12.3 Global Narcotic (Opioid) Drugs Forecast by End User/Segment
12.3.1 Global Narcotic (Opioid) Drugs Sales Volume Forecast by End User/Segment
12.3.2 Global Narcotic (Opioid) Drugs Sales Value Forecast by End User/Segment
12.3.3 Global Narcotic (Opioid) Drugs Price Forecast by End User/Segment
13 Global Narcotic (Opioid) Drugs Market Forecast by Region/Country
13.1 Global Narcotic (Opioid) Drugs Market Forecast by Region (2022-2027)
13.1.1 Global Narcotic (Opioid) Drugs Sales Volume Forecast by Region (2022-2027)
13.1.2 Global Narcotic (Opioid) Drugs Sales Value Forecast by Region (2022-2027)
13.2 North America Market Forecast
13.3 Europe Market Forecast
13.4 Asia Pacific Market Forecast
…………..Continued
CONTACT DETAILS
[email protected]
+44 203 500 2763
+1 62 825 80070
971 0503084105